Expert Interviews

Journavx is the first and only approved non-opioid oral pain signal inhibitor and the first new class of pain medicine approved in more than 20 years.

Data showed that brexpiprazole plus sertraline significantly improved PTSD symptoms vs sertraline alone. Lead author, Lori Davis, MD, discusses more.

Todd W. Frieze, MD, concludes this series discussing differences in benign vs cancerous tumors and key final takeaways.

Todd W. Frieze, MD, highlights the various ways to accurately assess patient thyroid hormone levels and the general guidelines on patient surveillance.

Todd W. Frieze, MD, discusses various suppression therapy approaches for patients with hypothyroidism and thyroid cancer.

Alex Tessnow, MD, concludes this series with key final takeaways.

Alex Tessnow, MD, reviews treatment approaches for elderly patients with hypothyroidism.

Alex Tessnow, MD, discusses the common symptoms and red flags associated with hypothyroidism in elderly patients.

Alex Tessnow, MD, highlights the variability of hypothyroidism among elderly patients.

Dr Turner reviews the profile of the individual who is most likely to benefit from lecanemab therapy.